1. Home
  2. IKNA vs NHTC Comparison

IKNA vs NHTC Comparison

Compare IKNA & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • NHTC
  • Stock Information
  • Founded
  • IKNA 2016
  • NHTC 1988
  • Country
  • IKNA United States
  • NHTC United States
  • Employees
  • IKNA N/A
  • NHTC N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • IKNA Health Care
  • NHTC Miscellaneous
  • Exchange
  • IKNA Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • IKNA 61.8M
  • NHTC 56.0M
  • IPO Year
  • IKNA 2021
  • NHTC 1995
  • Fundamental
  • Price
  • IKNA $1.08
  • NHTC $4.96
  • Analyst Decision
  • IKNA Buy
  • NHTC
  • Analyst Count
  • IKNA 2
  • NHTC 0
  • Target Price
  • IKNA $3.00
  • NHTC N/A
  • AVG Volume (30 Days)
  • IKNA 95.3K
  • NHTC 17.1K
  • Earning Date
  • IKNA 05-20-2025
  • NHTC 04-30-2025
  • Dividend Yield
  • IKNA N/A
  • NHTC 16.14%
  • EPS Growth
  • IKNA N/A
  • NHTC N/A
  • EPS
  • IKNA N/A
  • NHTC 0.04
  • Revenue
  • IKNA N/A
  • NHTC $42,749,000.00
  • Revenue This Year
  • IKNA N/A
  • NHTC N/A
  • Revenue Next Year
  • IKNA N/A
  • NHTC N/A
  • P/E Ratio
  • IKNA N/A
  • NHTC $122.84
  • Revenue Growth
  • IKNA N/A
  • NHTC N/A
  • 52 Week Low
  • IKNA $0.97
  • NHTC $4.02
  • 52 Week High
  • IKNA $1.94
  • NHTC $7.40
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 37.62
  • NHTC 49.28
  • Support Level
  • IKNA $1.22
  • NHTC $4.88
  • Resistance Level
  • IKNA $1.29
  • NHTC $5.08
  • Average True Range (ATR)
  • IKNA 0.09
  • NHTC 0.11
  • MACD
  • IKNA -0.01
  • NHTC 0.00
  • Stochastic Oscillator
  • IKNA 1.75
  • NHTC 45.70

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: